Literature DB >> 21693142

PAC1hop, null and hip receptors mediate differential signaling through cyclic AMP and calcium leading to splice variant-specific gene induction in neural cells.

Yvonne Holighaus1, Tomris Mustafa, Lee E Eiden.   

Abstract

Pituitary adenylate cyclase-activating polypeptide (PACAP)-mediated activation of its G protein-coupled receptor PAC1 results in activation of the two G proteins Gs and Gq to alter second messenger generation and gene transcription in the nervous system, important for homeostatic responses to stress and injury. Heterologous expression of the three major splice variants of the rat PAC1 receptor, PAC1hop, null and hip, in neural NG108-15 cells conferred PACAP-mediated intracellular cAMP generation, while elevation of [Ca(2+)](i) occurred only in PAC1hop-, and to a lesser extent in PAC1null-expressing cells. Induction of vasoactive intestinal polypeptide (VIP) and stanniocalcin 1 (STC1), two genes potentially involved in PACAP's homeostatic responses, was examined as a function of the expressed PAC1 variant. VIP induction was greatest in PAC1hop-expressing cells, suggesting that a maximal transcriptional response requires combinatorial signaling through both cAMP and Ca(2+). STC1 induction was similar for all three receptor splice variants and was mimicked by the adenylate cyclase activator forskolin, indicating that cAMP elevation is sufficient to induce STC1. The degree of activation of two different second messenger pathways appears to determine the transcriptional response, suggesting that cellular responses to stressors are fine-tuned through differential receptor isoform expression. Signaling to the VIP gene proceeded through cAMP and protein kinase A (PKA) in these cells, independently of the MAP kinase ERK1/2. STC1 gene induction by PACAP was dependent on cAMP and ERK1/2, independently of PKA. Differential gene induction via different cAMP dependent signaling pathways potentially provides further targets for the design of treatments for stress-associated disorders. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21693142      PMCID: PMC3163081          DOI: 10.1016/j.peptides.2011.06.004

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  67 in total

1.  PAC1hop receptor activation facilitates catecholamine secretion selectively through 2-APB-sensitive Ca(2+) channels in PC12 cells.

Authors:  Tomris Mustafa; James Walsh; Maurizio Grimaldi; Lee E Eiden
Journal:  Cell Signal       Date:  2010-05-12       Impact factor: 4.315

2.  Hypoxic preconditioning induces neuroprotective stanniocalcin-1 in brain via IL-6 signaling.

Authors:  Johan A Westberg; Martina Serlachius; Petri Lankila; Milena Penkowa; Juan Hidalgo; Leif C Andersson
Journal:  Stroke       Date:  2007-02-01       Impact factor: 7.914

3.  Cellular distribution of the splice variants of the receptor for pituitary adenylate cyclase-activating polypeptide (PAC(1)-R) in the rat brain by in situ RT-PCR.

Authors:  C J Zhou; S Kikuyama; M Shibanuma; T Hirabayashi; S Nakajo; A Arimura; S Shioda
Journal:  Brain Res Mol Brain Res       Date:  2000-01-10

4.  Synergistic induction of pituitary adenylate cyclase-activating polypeptide (PACAP) gene expression by nerve growth factor and PACAP in PC12 cells.

Authors:  H Hashimoto; N Hagihara; K Koga; K Yamamoto; N Shintani; S Tomimoto; W Mori; Y Koyama; T Matsuda; A Baba
Journal:  J Neurochem       Date:  2000-02       Impact factor: 5.372

5.  The 38-amino-acid form of pituitary adenylate cyclase-activating polypeptide induces neurite outgrowth in PC12 cells that is dependent on protein kinase C and extracellular signal-regulated kinase but not on protein kinase A, nerve growth factor receptor tyrosine kinase, p21(ras) G protein, and pp60(c-src) cytoplasmic tyrosine kinase.

Authors:  P Lazarovici; H Jiang; D Fink
Journal:  Mol Pharmacol       Date:  1998-09       Impact factor: 4.436

6.  Second messenger-dependent protein kinases and protein synthesis regulate endogenous secretin receptor responsiveness.

Authors:  Roxana S Ghadessy; Eamonn Kelly
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

7.  Pituitary adenylate cyclase-activating polypeptide protects rat-cultured cortical neurons from glutamate-induced cytotoxicity.

Authors:  H Morio; I Tatsuno; A Hirai; Y Tamura; Y Saito
Journal:  Brain Res       Date:  1996-11-25       Impact factor: 3.252

8.  Discovery of pituitary adenylate cyclase-activating polypeptide-regulated genes through microarray analyses in cell culture and in vivo.

Authors:  Lee E Eiden; Babru Samal; Matthew J Gerdin; Tomris Mustafa; David Vaudry; Nikolas Stroth
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

9.  Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide.

Authors:  T Ishihara; R Shigemoto; K Mori; K Takahashi; S Nagata
Journal:  Neuron       Date:  1992-04       Impact factor: 17.173

10.  Differential signaling and immediate-early gene activation by four splice variants of the human pituitary adenylate cyclase-activating polypeptide receptor (hPACAP-R).

Authors:  J R Pisegna; T W Moody; S A Wank
Journal:  Ann N Y Acad Sci       Date:  1996-12-26       Impact factor: 5.691

View more
  20 in total

Review 1.  Is PACAP the major neurotransmitter for stress transduction at the adrenomedullary synapse?

Authors:  Corey B Smith; Lee E Eiden
Journal:  J Mol Neurosci       Date:  2012-05-18       Impact factor: 3.444

2.  Pituitary Adenylate Cyclase-Activating Polypeptide Receptors Signal via Phospholipase C Pathway to Block Apoptosis in Newborn Rat Retina.

Authors:  Monika Lakk; Viktoria Denes; Robert Gabriel
Journal:  Neurochem Res       Date:  2015-05-15       Impact factor: 3.996

3.  A new site and mechanism of action for the widely used adenylate cyclase inhibitor SQ22,536.

Authors:  Andrew C Emery; Maribeth V Eiden; Lee E Eiden
Journal:  Mol Pharmacol       Date:  2012-10-10       Impact factor: 4.436

4.  Pituitary adenylate cyclase-activating polypeptide (PACAP) signalling enhances osteogenesis in UMR-106 cell line.

Authors:  Tamás Juhász; Csaba Matta; Éva Katona; Csilla Somogyi; Roland Takács; Tibor Hajdú; Solveig Lind Helgadottir; János Fodor; László Csernoch; Gábor Tóth; Éva Bakó; Dóra Reglődi; Andrea Tamás; Róza Zákány
Journal:  J Mol Neurosci       Date:  2014-08-12       Impact factor: 3.444

5.  Signaling pathways and promoter regions that mediate pituitary adenylate cyclase activating polypeptide (PACAP) self-regulation in gonadotrophs.

Authors:  Rongquiang Yang; Stephen J Winters; Joseph P Moore
Journal:  Mol Cell Endocrinol       Date:  2020-05-18       Impact factor: 4.102

6.  STC1 induction by PACAP is mediated through cAMP and ERK1/2 but not PKA in cultured cortical neurons.

Authors:  Yvonne Holighaus; Eberhard Weihe; Lee E Eiden
Journal:  J Mol Neurosci       Date:  2012-01       Impact factor: 3.444

7.  C-terminal amidation of PACAP-38 and PACAP-27 is dispensable for biological activity at the PAC1 receptor.

Authors:  Andrew C Emery; Ryan A Alvarez; Philip Abboud; Wenqin Xu; Craig D Westover; Maribeth V Eiden; Lee E Eiden
Journal:  Peptides       Date:  2016-03-11       Impact factor: 3.750

Review 8.  PACAP deficiency as a model of aging.

Authors:  D Reglodi; T Atlasz; E Szabo; A Jungling; A Tamas; T Juhasz; B D Fulop; A Bardosi
Journal:  Geroscience       Date:  2018-10-22       Impact factor: 7.713

Review 9.  Vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide, and their receptors and cancer.

Authors:  Terry W Moody; Bernardo Nuche-Berenguer; Robert T Jensen
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-02       Impact factor: 3.243

Review 10.  Pleiotropic pituitary adenylate cyclase-activating polypeptide (PACAP): Novel insights into the role of PACAP in eating and drug intake.

Authors:  Andrew T Gargiulo; Genevieve R Curtis; Jessica R Barson
Journal:  Brain Res       Date:  2019-12-26       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.